Quest Diagnostics Projects 9% EPS Growth, Unveils Strategic Growth Plan
Provides long-term outlook beyond 2025: Revenues expected to grow at 4-5% compound annual growth rate (CAGR); adjusted diluted earnings per...
diagnostics
India-made TB diagnostics tech wins acclaim at World Health Assembly
Sriram Natarajan (fourth from left), founder and CEO, Molbio, was part of a panel at the WHA, discussing point-of care...
